The demand for therapeutic drugs has increased due to the onset of various life-threatening diseases. As a result, biopharmaceutical manufacturers are looking for effective and efficient manufacturing methods, leading to the growth of single-use products (SUTs). In addition to small-scale production, these technologies have also become popular among large contract manufacturing organizations. Furthermore, SUTs are expected to continue to improve the purification of monoclonal antibodies and recombinant proteins.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/4903
These systems are becoming increasingly popular among biopharmaceutical companies due to several advantages compared to the use of stainless steel systems. They also reduce capital investment and require minimal cleaning and sterilization time. Moreover, single-use systems are also flexible and scalable. Therefore, they are the most suitable option for manufacturing clinical trial materials. In addition, they are also a cost-effective solution for biopharmaceutical manufacturing.
Global Single Use Products in Biopharmaceuticals Market – Impact of the Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, on November 11, 2021, Single Use Support, a provider and manufacturer of storing, freezing, filing, thawing, and shipping solutions for drug substances, published an article described the shortage on single use assemblies in pharmaceutical market as the research and developments activities increase for vaccine production for COVID 19, where early stage clinical products rely on small volume production for trials and bulk drug requirement can be scaled up to correct volume.
The increasing inorganic activities such as agreements, expansion, and partnerships in different regions by market players for manufacturing single use products in biopharmaceutical is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, on November 6, 2020, Cytiva, a technological products and services in field of bioprocessing, manufacturing, research and developments, and provider of therapeutics signed agreements with Wego, Clover is cloud-based Android point of sale platform, Jinbo, and Zhifei a company of high-tech biological enterprise integrating the R&D, production, marketing for investments in the production of therapeutics and to scale up the protein based COVID-19 S-Trimmer subunit vaccine in China.
The global single use products in biopharmaceuticals market is estimated to be valued at US$ 1,821.2 Mn in 2021 and is expected to exhibit a CAGR of 16.7% over the forecast period (2021-2028).
Increasing investment in single use products by the market players used for biopharmaceutical industry is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period.
The increasing investments in single use products for pharmaceutical processing is expected to fuel growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, In December 2019, Lonza, a global partner of biotech, pharmaceutical markets has announced investment of US$ 92 million for building new large scale facility with 20,000L bioreactors to fulfill the market demand of biologics, where single use technology facility will support the clinical manufacturing processes.
Market players are engaged in launching products and applying for approval from regulatory authorities indicated for use in biopharmaceutical processing. This is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period.
Get PDF Sample Copy of Report (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-sample/4903
Growing approvals from the regulatory authorities and launches of products are expected to drive growth of the market over the forecast period. For instance, on February 9, 2021, 3M health care, a drug development company’ designed single use AEX solution for biologic drug manufacturing. This manufacturing workflow will help in reducing the number of processing steps of manufacturing product for improving processing.
Global Single Use Products in Biopharmaceuticals Market – Regional Analysis
On the basis of region, global single use products in biopharmaceuticals market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold a leading position over the forecast period, due to the expansion of production unit by market players. For instance, on September 27, 2021, Sartorius AG, a pharmaceutical and laboratory equipment supplier, announced expansion business operations of bioprocessing unit in North America region. This expand will benefit the region because drug availability will grow as transportation costs decrease.
Furthermore, Europe is also projected to witness a significant growth in the single use products in biopharmaceuticals market, due to growing investments by the market players and research institute. For instance, on March 17, 2021, Merck KGaA, which is a company of leading science and technology announced the expansion of single use assembly production unit in France to manufacture COVID-19 vaccines and therapies and the company has invested US$ 28 million for development of the unit.
Global Single Use Products in Biopharmaceuticals Market – Competitive Landscape
Major players operating in the global single use products in biopharmaceuticals market include Aber instruments, Adolf Kühner AG, Thermo Fisher Scientific, Bio-equip, Pall corp., C-Cit Sensors AG, Corning Life Sciences, Eppendorf, GE Healthcare, Gemu GmbH, Merck, Avantor, Meissner, New Horizon Biotech, PBS-Biotech, Xcellerex, and Single Use Support GmbH.
Buy This Report with Flat USD 2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/4903
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Single Use Products in Biopharmaceuticals Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Single Use Products in Biopharmaceuticals Industry Impact
Chapter 2 Global Single Use Products in Biopharmaceuticals Competition by Types, Applications, and Top Regions and Countries
2.1 Global Single Use Products in Biopharmaceuticals (Volume and Value) by Type
2.3 Global Single Use Products in Biopharmaceuticals (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Single Use Products in Biopharmaceuticals Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Single Use Products in Biopharmaceuticals Market Analysis
Chapter 6 East Asia Single Use Products in Biopharmaceuticals Market Analysis
Chapter 7 Europe Single Use Products in Biopharmaceuticals Market Analysis
Chapter 8 South Asia Single Use Products in Biopharmaceuticals Market Analysis
Chapter 9 Southeast Asia Single Use Products in Biopharmaceuticals Market Analysis
Chapter 10 Middle East Single Use Products in Biopharmaceuticals Market Analysis
Chapter 11 Africa Single Use Products in Biopharmaceuticals Market Analysis
Chapter 12 Oceania Single Use Products in Biopharmaceuticals Market Analysis
Chapter 13 South America Single Use Products in Biopharmaceuticals Market Analysis
Chapter 14 Company Profiles and Key Figures in Single Use Products in Biopharmaceuticals Business
Chapter 15 Global Single Use Products in Biopharmaceuticals Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837